Tafero-EM is a recently launched drug for the treatment of HIV and hepatitis B. The Tafero-EM tablet contains the active ingredients Emtricitabine (Emtricitabine) 200 mg and Tenofovir Alafenamide (Tenofovir Alafenamide) 25 mg, which helps stop the growth of the HBV and hiv virus in the blood.
Disclaimer : This information should not be used to decide whether or not to take this Product or any other medicine. Only the healthcare provider has the knowledge and training to decide which medicines are right for a specific patient. This information does not endorse any medicine as safe, effective, or approved for treating any patient or health condition. This is only a brief summary of general information about this Product . It does NOT include all information about the possible uses, directions, warnings, precautions, interactions, adverse effects, or risks that may apply to this product. This information is not specific medical advice and does not replace information you receive from the healthcare provider. You must talk with the healthcare provider for complete information about the risks and benefits of using this product.